Fulcrum Therapeutics, Inc. FULC
NASDAQ · United States · Health Technology
$3.69+0.01 (+0.27%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Price reaction |
|---|---|---|---|---|---|
| Q2 2026 | 2026-07-30 | -0.34 | -0.26 | -33.1% | -1.1%$3.62→$3.58 |
| Q1 2026 | 2026-04-27 | -0.25 | -0.30 | +16.7% | -5.1%$7.84→$7.44 |
| Q4 2025 | 2026-02-24 | -0.31 | -0.31 | 0.0% | -17.5%$10.89→$8.98 |
| Q3 2025 | 2025-10-29 | -0.31 | -0.29 | -6.9% | -14.0%$10.00→$8.60 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.